| Aug 7 |
CytomX Q2 2024 Earnings Preview
|
| Aug 1 |
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
|
| Jul 25 |
CytomX Therapeutics, Inc. (CTMX): The Best One-Dollar Stock to Buy Now?
|
| Jul 22 |
CytomX Therapeutics, Inc. (NASDAQ:CTMX) is definitely on the radar of institutional investors who own 47% of the company
|
| Jul 15 |
CytomX Therapeutics' Probody Platform: Potential And Pitfalls In Oncology Treatments
|
| Jun 18 |
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
|
| Jun 17 |
CytomX Therapeutics promotes Chris Ogden to CFO
|
| Jun 17 |
CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
|
| Jun 5 |
(CTMX) - Analyzing CytomX Therapeutics's Short Interest
|
| Jun 5 |
Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago
|
